Imatinib vs Pembrolizumab

## Imatinib vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Imatinib** and **Pembrolizumab**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Imatinib — 18 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Imatinib — C29H31N7O; Pembrolizumab — N/A.

**Molecular Weight**: Imatinib — 493.6030 g/mol; Pembrolizumab — N/A.

**Type**: Imatinib — Small molecule; Pembrolizumab — Antibody.